Snapshot Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload The global Deferiprone market size is estimated at xxx million USD with a CAGR xx% from 2017-2022 and is expected to reach xxx Million USD in 2022 with a CAGR xx% from 2022 to 2028. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Deferiprone by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Tablet Oral Solution Capsule Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.): Apotex Cipla Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Transfusional Iron Overload NTDT Caused Iron Overload Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc.) Asia-Pacific (China, India, Japan, Southeast Asia etc.) South America (Brazil, Argentina etc.) Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents 1 Industry Overview 1.1 Deferiprone Industry Figure Deferiprone Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Deferiprone 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Deferiprone 1.2.2 Downstream Table Application Segment of Deferiprone Table Globa
